Story perspectives

Study: mRNA Vaccines Could Double Cancer Survival Rates

10/27/2025

50 9

Summary

Story summary

A study published in Nature suggests COVID-19 mRNA vaccines may enhance cancer treatment by activating the immune system.
Researchers analyzed medical records of more than 1,000 patients with lung cancer and melanoma.
Patients vaccinated with Pfizer Inc. or Moderna, Inc. vaccines experienced nearly double survival time versus unvaccinated patients.
Future clinical trials will validate these findings and may integrate mRNA vaccines into standard cancer therapies.

1 of 1

Story summary

A study published in Nature suggests COVID-19 mRNA vaccines may enhance cancer treatment by activating the immune system.
Researchers analyzed medical records of more than 1,000 patients with lung cancer and melanoma.
Patients vaccinated with Pfizer Inc. or Moderna, Inc. vaccines experienced nearly double survival time versus unvaccinated patients.
Future clinical trials will validate these findings and may integrate mRNA vaccines into standard cancer therapies.